VistaGen Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $1,476 | $465 | $303 | $258 |
Gross Profit | 1,279 | 465 | 114 | 258 |
EBITDA | -12,833 | -16,527 | -18,710 | -19,232 |
EBIT | -13,030 | -16,717 | -18,899 | -19,417 |
Net Income | -13,030 | -16,274 | -18,899 | -19,417 |
Net Change In Cash | 1,476 | 465 | 303 | 258 |
Free Cash Flow | -14,707 | -16,200 | -17,571 | -13,819 |
Cash | 16,991 | 30,789 | 47,371 | 62,786 |
Basic Shares | 42,980 | 39,620 | 42,234 | 35,749 |
Annual Financials
| Values in thousands | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
Revenue | $1,269 | $486 | $1,064 | $-227 |
Gross Profit | 1,269 | 486 | 1,064 | -227 |
EBITDA | -71,393 | -50,776 | -28,790 | -58,736 |
EBIT | -72,126 | -51,411 | -29,358 | -59,268 |
Net Income | -69,685 | -51,418 | -29,362 | -59,247 |
Net Change In Cash | 1,269 | 486 | 1,064 | -227 |
Free Cash Flow | -66,436 | -42,288 | -25,874 | -49,927 |
Cash | 30,789 | 67,131 | 119,166 | 16,638 |
Basic Shares | 38,073 | 30,877 | 19,354 | 6,958 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.30 |
2026-03-31 | -$0.37 |
2025-12-31 | -$0.45 |
2025-09-30 | -$0.54 |